[go: up one dir, main page]

NO20006334D0 - Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav - Google Patents

Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav

Info

Publication number
NO20006334D0
NO20006334D0 NO20006334A NO20006334A NO20006334D0 NO 20006334 D0 NO20006334 D0 NO 20006334D0 NO 20006334 A NO20006334 A NO 20006334A NO 20006334 A NO20006334 A NO 20006334A NO 20006334 D0 NO20006334 D0 NO 20006334D0
Authority
NO
Norway
Prior art keywords
hepatitis
preparation
treatment
pharmaceutical formulation
viral liver
Prior art date
Application number
NO20006334A
Other languages
English (en)
Other versions
NO20006334L (no
Inventor
Sadras Panchatchar Thyagarajan
Original Assignee
Univ Madras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Madras filed Critical Univ Madras
Publication of NO20006334D0 publication Critical patent/NO20006334D0/no
Publication of NO20006334L publication Critical patent/NO20006334L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20006334A 1999-04-12 2000-12-12 Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav NO20006334L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN405MA1999 1999-04-12
PCT/IN2000/000046 WO2000061161A2 (en) 1999-04-12 2000-04-10 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation

Publications (2)

Publication Number Publication Date
NO20006334D0 true NO20006334D0 (no) 2000-12-12
NO20006334L NO20006334L (no) 2001-02-12

Family

ID=11095076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006334A NO20006334L (no) 1999-04-12 2000-12-12 Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav

Country Status (9)

Country Link
US (1) US6589570B1 (no)
EP (1) EP1091748A2 (no)
JP (1) JP2002541204A (no)
AU (2) AU5425400A (no)
CA (1) CA2334754A1 (no)
GB (1) GB2355932B (no)
MX (1) MXPA00012330A (no)
NO (1) NO20006334L (no)
WO (2) WO2000061161A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
US20030129251A1 (en) 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
US7129222B2 (en) 2000-03-10 2006-10-31 Dynavax Technologies Corporation Immunomodulatory formulations and methods for use thereof
DE10030139A1 (de) * 2000-06-20 2002-01-10 Cmi Ag Verwendung von Phyllanthusbesandteilen zur Behandlung oder Prophylaxe von Infekten durch Flaviviridae
DE10120627A1 (de) 2001-04-26 2002-10-31 Cmi Ag Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren
WO2003014316A2 (en) 2001-08-07 2003-02-20 Dynavax Technologies Corporation Immunomodulatory compositions, formulations, and methods for use thereof
ATE544453T1 (de) * 2002-07-15 2012-02-15 Gilead Sciences Inc Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen
AU2004204827B2 (en) * 2003-01-13 2006-06-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
JP2006522144A (ja) * 2003-04-04 2006-09-28 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 下部尿路障害の治療方法
CA2573185A1 (en) * 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7645881B2 (en) * 2004-07-22 2010-01-12 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
ATE521359T1 (de) 2005-01-25 2011-09-15 Neumed Inc Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall
EP2116253A1 (en) * 2008-05-07 2009-11-11 Phytrix JV, LLC Novel phyllanthus extract
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
EP2583680A3 (en) 2011-10-21 2013-06-12 Abbvie Inc. Mono (PSI-7977) or combination treatment of DAAs for use in treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
AU2013201406B2 (en) 2011-10-21 2014-10-02 Abbvie Ireland Unlimited Company Methods for treating HCV
WO2017189978A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0890360B1 (en) * 1997-04-21 2003-01-02 Dabur Research Foundation A polyherbal pharmaceutical composition useful in the treatment of conditions associated with hepatitis E and hepatitis B virus infections
AU4947700A (en) 1999-03-24 2000-10-09 Southern Petrochemical Industries Corporation Limited An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Also Published As

Publication number Publication date
WO2000061161A3 (en) 2001-02-08
GB0029936D0 (en) 2001-01-24
GB2355932A (en) 2001-05-09
GB2355932B (en) 2004-01-07
EP1091748A2 (en) 2001-04-18
WO2000061160A2 (en) 2000-10-19
WO2000061160A3 (en) 2001-01-25
AU5425400A (en) 2000-11-14
JP2002541204A (ja) 2002-12-03
AU4309500A (en) 2000-11-14
MXPA00012330A (es) 2004-12-03
WO2000061161A2 (en) 2000-10-19
US6589570B1 (en) 2003-07-08
CA2334754A1 (en) 2000-10-19
NO20006334L (no) 2001-02-12

Similar Documents

Publication Publication Date Title
NO20006334D0 (no) Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav
EE05442B1 (et) V„ikeses annuses entekaviiri sisaldav ravimkoostis B-hepatiidi viirusinfektsiooni raviks ning meetod selle valmistamiseks
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69737793D1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
DK2050445T4 (da) Farmaceutisk sammensætning af phenofibrat med forøget biotilgængelighed samt fremgangsmåde til dens fremstilling
IL215891A (en) Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections
NO20053920D0 (no) Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler.
ID27457A (id) Komposisi untuk pengobatan hiv dan infeksi virus lainnya
NO20013667D0 (no) Fremgangsmåte ved fremstilling av 5-cyanoftalid
NO20013569L (no) Fremgangsmate ved fremstilling av L-fenylephrine-hydroklorid
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20022816L (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
NO20005000D0 (no) FremgangsmÕte for fremstilling av rÕstoffer for glassfremstilling
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO20041855L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon ved behandling av feilpasienter
NO20021066D0 (no) Fremgangsmåte ved fremstilling av tricykliske aminoalkoholderivater
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
NO20041685L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon hos pasienter med manglende behandlingsrespons
NO20020073D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application